These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass. Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115 [TBL] [Abstract][Full Text] [Related]
8. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation. Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397 [TBL] [Abstract][Full Text] [Related]
9. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively. Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258 [TBL] [Abstract][Full Text] [Related]
10. [Measurement of activated clotting time during cardiopulmonary bypass in infective endocarditis patients]. Jiang L; Yu JF Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):167-9. PubMed ID: 17344611 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass. Akl BF; Vargas GM; Neal J; Robillard J; Kelly P J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393 [TBL] [Abstract][Full Text] [Related]